Committee

Biogen Says EU Committee Issues Positive View on FLIXABI to Treat Rheumatoid …
Biogen's (NASDAQ:BIIB) FLIXABI shares were practically unchanged on Friday after the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinion for the marketing authorization of FLIXABI for adults suffering ... [...]
1
Like
Save
FDA's Arthritis Advisory Committee Recommends Approval of Celltrion's CT-P13 …
Celltrion is seeking approval of CT-P13 for the treatment of a variety of serious autoimmune diseases, including Crohn's disease, ulcerative colitis and rheumatoid arthritis, among others. The Committee based its recommendation on the totality of ... [...]
1
Like
Save
FDA Committee Recommends Infliximab Biosimilar
Celltrion is seeking approval of CT-P13 for the treatment of a variety of autoimmune diseases, including Crohn's disease, ulcerative colitis, and rheumatoid arthritis. If approved by FDA, Pfizer would assume commercialization rights for the medication ... [...]
2
Like
Save